LRA Brings Encouraging News from European Rheumatology Meeting
June 2, 2022
The Lupus Research Alliance (LRA) and its clinical trial arm Lupus Therapeutics congratulate Bristol Myers Squibb (BMS)...
Albert Roy
Lupus Research Alliance and Lupus Therapeutics Response to Positive Data from Phase 2 Study on Potential First-in-class Lupus Treatment
The Lupus Research Alliance (LRA) and its clinical affiliate Lupus Therapeutics congratulate Bristol Myers Squibb (BMS) on new positive...
Thanks to LADA for Major Donation to Research Funding
August 24, 2021
We give a big thank you to the Lupus and Allied Diseases Association, Inc. (LADA) for their generous donation...
Lupus Research Lifted Up in Everyday Health
May 27, 2021
Funding innovative research year-round is the most meaningful way the Lupus Research Alliance Lifts Up Lupus with...
Join LRA March 11 to Learn What’s New in Lupus Nephritis
What’s New in Lupus Nephritis? A Research & Treatment Update
A Learn from Lupus Webcast
Lupus nephritis is a common and dangerous...
Watch Webcast Video: Redefining Lupus Trials Amid COVID-19 and Beyond
Videotape of 8.24.20 Learn from Lupus Zoom Webcast
Ensuring the clinical trial process is accommodating for participants has always been...
Lupus and COVID-19: What You Need to Know – LIVE WEBCAST May 21 at 6 PM ET
Since the arrival of the novel coronavirus, lupus and the most prescribed drug used to treat it – hydroxychloroquine...
VALUE Study Results Reported at EULAR
MADRID, Spain. June 13, 2019 – Results of the first clinical trial conducted through the Lupus Research Alliance Lupus...
Lupus Therapeutics Launches Peer Training Program to Help Patients Benefit from Clinical Trials
NEW YORK, NY. February 1, 2019. Lupus Research Alliance clinical affiliate Lupus Therapeutics launched the Patient Advocates for Lupus Studies...